Amy Raskopf | Vice President-Investor Relations |
Saundra Pelletier | Chief Executive Officer, President and Executive Director |
Jay File | Chief Financial Officer |
Katherine Atkinson | Chief Commercial Officer |
David Amsellem | Piper Sandler |
Yale Jen | Laidlaw and Company |
Stacy Lee | Stifel |
Ram Selvaraju | H.C. Wainwright |
Good afternoon.
Now, I'll turn the call over to Amy Raskopf, Evofem Biosciences' Vice President of Investor Relations. Please go ahead.
Thank you, Larry. Good afternoon, everyone, and welcome to the Evofem Biosciences’ results call for the second quarter of 2022.